SONALI THAKORE: Open Payments
NPI 1023559051 · WHITTIER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,980 in 99 payments from 32 companies in 2025. Trend: 2023 $569 · 2024 $2,433 · 2025 $2,980
Food & beverage: $2,980
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $524 |
| Merck Sharp & Dohme LLC | 14 | $436 |
| PUMA BIOTECHNOLOGY, INC. | 4 | $203 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $195 |
| PFIZER INC. | 9 | $185 |
| Novartis Pharmaceuticals Corporation | 6 | $182 |
| Lilly USA, LLC | 5 | $150 |
| Daiichi Sankyo Inc. | 4 | $109 |
| Ipsen Biopharmaceuticals, Inc | 3 | $86 |
| ABBVIE INC. | 4 | $83 |
Products named: KEYTRUDA, RYBREVANT, NERLYNX, ERLEADA, FRUZAQLA, KISQALI, VERZENIO, Trodelvy.
Industry payments across CA — which companies pay providers there.
